Desmethylmisonidazole is a nitroimidazole derivative and a metabolite of misonidazole, used mainly in experimental and research settings. Used as a hypoxic cell radiosensitizer in cancer research, especially in radiotherapy studies. Investigated for its ability to enhance the effect of ionizing radiation on oxygen-deficient tumor cells. Serves as a biological marker for tissue hypoxia in experimental models. Used in the study of nitroimidazole metabolism and toxicity profiles. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Demethylmisonidazole. It is also listed for alternate use as: API Impurity. Its PubChem CID is 26106.
Desmethylmisonidazole
| CAS No | 13551-92-3 |
|---|---|
| Molecular Formula | C6H9N3O4 |
| Molecular Weight | 187.15 g/mol |
| Synonyms | 3-(2-nitroimidazol-1-yl)propane-1,2-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Desmethylmisonidazole is a nitroimidazole derivative and a metabolite of misonidazole, used mainly in experimental and research settings. Used as a hypoxic cell radiosensitizer in cancer research, especially in radiotherapy studies.
The listed CAS number is 13551-92-3.
The listed molecular formula is C6H9N3O4.
The listed molecular weight is 187.15 g/mol.
3-(2-nitroimidazol-1-yl)propane-1,2-diol.
The source lists Demethylmisonidazole.